Cogent Biosciences, Inc. (COGT)
36.95
+1.25
(+3.50%)
USD |
NASDAQ |
Feb 06, 15:38
Cogent Biosciences Market Cap : 5.672B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 154.54B |
| Ionis Pharmaceuticals, Inc. | 13.94B |
| Sarepta Therapeutics, Inc. | 1.940B |
| Cidara Therapeutics, Inc. | 6.962B |
| Olema Pharmaceuticals, Inc. | 1.751B |
Market Cap Related Metrics
| PEG Ratio | -16.19 |
| Price to Book Value | 29.15 |
| Price | 36.95 |
| Earnings Yield | -6.42% |
| PEGY Ratio | -16.19 |